UltraVision sees beyond industry-standard mammography to introduce a patent-pending ultrasonic method for breast cancer screening – potentially reducing the pain and cost associated with screening while increasing access to early and frequent screenings for the 1 in 8 U.S. women diagnosed in their lifetime.
BioSensics is a global leader in development of wearable sensors and digital technologies for clinical trials and healthcare. Since its establishment, BioSensics has created new paradigms in using wearable sensors in healthcare and revolutionized the medical alert industry by creating technologies that are now being used by thousands of older adults.
Block’s LaserWarn™ product saves lives by providing early warning of a chemical attack on civilians or soldiers. Block’s LaserTune™ is sold to universities and corporate labs worldwide, leading to innovation in key research areas – from cancer pathology to graphene materials research, and wastewater treatment monitoring.